ID   TRI18_HUMAN             Reviewed;         667 AA.
AC   O15344; B2RCG2; O75361; Q9BZX5;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 186.
DE   RecName: Full=E3 ubiquitin-protein ligase Midline-1;
DE            EC=2.3.2.27;
DE   AltName: Full=Midin;
DE   AltName: Full=Putative transcription factor XPRF;
DE   AltName: Full=RING finger protein 59;
DE   AltName: Full=RING finger protein Midline-1;
DE   AltName: Full=RING-type E3 ubiquitin transferase Midline-1 {ECO:0000305};
DE   AltName: Full=Tripartite motif-containing protein 18;
GN   Name=MID1; Synonyms=FXY, RNF59, TRIM18, XPRF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS GBBB1 MET-438 DEL
RP   AND PHE-ILE-ASP-SER-GLY-ARG-HIS-LEU-534 INS.
RC   TISSUE=Neuron;
RX   PubMed=9354791; DOI=10.1038/ng1197-285;
RA   Quaderi N.A., Schweiger S., Gaudenz K., Franco B., Rugarli E.I.,
RA   Berger W., Feldman G.J., Volta M., Andolfi G., Gilgenkrantz S.,
RA   Marion R.W., Hennekam R.C.M., Opitz J.M., Muenke M., Ropers H.-H.,
RA   Ballabio A.;
RT   "Opitz G/BBB syndrome, a defect of midline development, is due to
RT   mutations in a new RING finger gene on Xp22.";
RL   Nat. Genet. 17:285-291(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9425238; DOI=10.1093/hmg/7.2.299;
RA   Perry J., Feather S., Smith A., Palmer S., Ashworth A.;
RT   "The human FXY gene is located within Xp22.3: implications for
RT   evolution of the mammalian X chromosome.";
RL   Hum. Mol. Genet. 7:299-305(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=9722948; DOI=10.1006/geno.1998.5350;
RA   Van den Veyver I.B., Cormier T.A., Jurecic V., Baldini A.,
RA   Zoghbi H.Y.;
RT   "Characterization and physical mapping in human and mouse of a novel
RT   RING finger gene in Xp22.";
RL   Genomics 51:251-261(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GBBB1 PRO-626.
RC   TISSUE=Brain;
RX   PubMed=11030761; DOI=10.1093/hmg/9.17.2553;
RA   Cox T.C., Allen L.R., Cox L.L., Hopwood B., Goodwin B., Haan E.,
RA   Suthers G.K.;
RT   "New mutations in MID1 provide support for loss of function as the
RT   cause of X-linked Opitz syndrome.";
RL   Hum. Mol. Genet. 9:2553-2562(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A.,
RA   Minucci S., Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=10400985; DOI=10.1093/hmg/8.8.1387;
RA   Cainarca S., Messali S., Ballabio A., Meroni G.;
RT   "Functional characterization of the Opitz syndrome gene product
RT   (midin): evidence for homodimerization and association with
RT   microtubules throughout the cell cycle.";
RL   Hum. Mol. Genet. 8:1387-1396(1999).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10077590; DOI=10.1073/pnas.96.6.2794;
RA   Schweiger S., Foerster J., Lehmann T., Suckow V., Muller Y.A.,
RA   Walter G., Davies T., Porter H., van Bokhoven H., Lunt P.W., Traub P.,
RA   Ropers H.H.;
RT   "The Opitz syndrome gene product, MID1, associates with
RT   microtubules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2794-2799(1999).
RN   [11]
RP   FUNCTION.
RX   PubMed=11685209; DOI=10.1038/ng762;
RA   Trockenbacher A., Suckow V., Foerster J., Winter J., Krauss S.,
RA   Ropers H.H., Schneider R., Schweiger S.;
RT   "MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that
RT   targets phosphatase 2A for degradation.";
RL   Nat. Genet. 29:287-294(2001).
RN   [12]
RP   INTERACTION WITH IGBP1, AND PHOSPHORYLATION.
RX   PubMed=11806752; DOI=10.1186/1471-2121-3-1;
RA   Short K.M., Hopwood B., Yi Z., Cox T.C.;
RT   "MID1 and MID2 homo- and heterodimerise to tether the rapamycin-
RT   sensitive PP2A regulatory subunit, Alpha 4, to microtubules:
RT   implications for the clinical variability of X-linked Opitz GBBB
RT   syndrome and other developmental disorders.";
RL   BMC Cell Biol. 3:1-1(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=22613722; DOI=10.1074/jbc.M112.368613;
RA   Watkins G.R., Wang N., Mazalouskas M.D., Gomez R.J., Guthrie C.R.,
RA   Kraemer B.C., Schweiger S., Spiller B.W., Wadzinski B.E.;
RT   "Monoubiquitination promotes calpain cleavage of the protein
RT   phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A
RT   stability and microtubule-associated protein phosphorylation.";
RL   J. Biol. Chem. 287:24207-24215(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92; SER-96 AND SER-511,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   STRUCTURE BY NMR OF 87-164.
RX   PubMed=16529770; DOI=10.1016/j.jmb.2006.02.009;
RA   Massiah M.A., Simmons B.N., Short K.M., Cox T.C.;
RT   "Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-
RT   box with a RING.";
RL   J. Mol. Biol. 358:532-545(2006).
RN   [21]
RP   VARIANTS GBBB1 ARG-266 AND THR-536.
RX   PubMed=9718340; DOI=10.1086/302010;
RA   Gaudenz K., Roessler E., Quaderi N.A., Franco B., Feldman G.J.,
RA   Gasser D.L., Wittwer B., Horst J., Montini E., Opitz J.M.,
RA   Ballabio A., Muenke M.;
RT   "Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in
RT   the carboxy-terminal domain.";
RL   Am. J. Hum. Genet. 63:703-710(1998).
RN   [22]
RP   ERRATUM.
RA   Gaudenz K., Roessler E., Quaderi N.A., Franco B., Feldman G.J.,
RA   Gasser D.L., Wittwer B., Horst J., Montini E., Opitz J.M.,
RA   Ballabio A., Muenke M.;
RL   Am. J. Hum. Genet. 63:1571-1571(1998).
RN   [23]
RP   VARIANTS GBBB1 PRO-295 AND 391-LEU-CYS-392 DELINS ARG.
RX   PubMed=15558842; DOI=10.1002/ajmg.a.30407;
RA   So J., Suckow V., Kijas Z., Kalscheuer V., Moser B., Winter J.,
RA   Baars M., Firth H., Lunt P., Hamel B.C.J., Meinecke P., Moraine C.,
RA   Odent S., Schinzel A., van der Smagt J.J., Devriendt K., Albrecht B.,
RA   Gillessen-Kaesbach G., van der Burgt I., Petrij F., Faivre L.,
RA   McGaughran J., McKenzie F., Opitz J.M., Cox T., Schweiger S.;
RT   "Mild phenotypes in a series of patients with Opitz GBBB syndrome with
RT   MID1 mutations.";
RL   Am. J. Med. Genet. A 132:1-7(2005).
CC   -!- FUNCTION: Has E3 ubiquitin ligase activity towards IGBP1,
CC       promoting its monoubiquitination, which results in deprotection of
CC       the catalytic subunit of protein phosphatase PP2A, and its
CC       subsequent degradation by polyubiquitination.
CC       {ECO:0000269|PubMed:10400985, ECO:0000269|PubMed:11685209,
CC       ECO:0000269|PubMed:22613722}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- SUBUNIT: Homodimer or heterodimer with MID2. Interacts with IGBP1.
CC       {ECO:0000269|PubMed:11806752, ECO:0000269|PubMed:22613722}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-2340316, EBI-2340316;
CC       Q13895:BYSL; NbExp=3; IntAct=EBI-2340316, EBI-358049;
CC       Q9NR20:DYRK4; NbExp=3; IntAct=EBI-2340316, EBI-3914009;
CC       Q08426:EHHADH; NbExp=5; IntAct=EBI-2340316, EBI-2339219;
CC       Q0VDC6:FKBP1A; NbExp=5; IntAct=EBI-2340316, EBI-10226858;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-2340316, EBI-10172181;
CC       Q96IK5:GMCL1; NbExp=7; IntAct=EBI-2340316, EBI-2548508;
CC       P50221:MEOX1; NbExp=6; IntAct=EBI-2340316, EBI-2864512;
CC       Q9UJV3-2:MID2; NbExp=10; IntAct=EBI-2340316, EBI-10172526;
CC       Q96DC9:OTUB2; NbExp=3; IntAct=EBI-2340316, EBI-746259;
CC       Q16512:PKN1; NbExp=3; IntAct=EBI-2340316, EBI-602382;
CC       Q8N8B7:TCEANC; NbExp=3; IntAct=EBI-2340316, EBI-954696;
CC       P51668:UBE2D1; NbExp=6; IntAct=EBI-2340316, EBI-743540;
CC       P62837:UBE2D2; NbExp=3; IntAct=EBI-2340316, EBI-347677;
CC       P61077:UBE2D3; NbExp=6; IntAct=EBI-2340316, EBI-348268;
CC       Q9Y2X8:UBE2D4; NbExp=3; IntAct=EBI-2340316, EBI-745527;
CC       Q96LR5:UBE2E2; NbExp=9; IntAct=EBI-2340316, EBI-2129763;
CC       Q969T4:UBE2E3; NbExp=6; IntAct=EBI-2340316, EBI-348496;
CC       P68036:UBE2L3; NbExp=3; IntAct=EBI-2340316, EBI-711173;
CC       Q9HAC8:UBTD1; NbExp=5; IntAct=EBI-2340316, EBI-745871;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10077590}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10077590}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:10077590}.
CC       Note=Microtubule-associated. It is associated with microtubules
CC       throughout the cell cycle, co-localizing with cytoplasmic fibers
CC       in interphase and with the mitotic spindle and midbodies during
CC       mitosis and cytokinesis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=O15344-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=O15344-2; Sequence=VSP_005735;
CC   -!- TISSUE SPECIFICITY: In the fetus, highest expression found in
CC       kidney, followed by brain and lung. Expressed at low levels in
CC       fetal liver. In the adult, most abundant in heart, placenta and
CC       brain.
CC   -!- INDUCTION: A retroviral element acts as an alternative tissue-
CC       specific promoter for this gene. The LTR of an HERV-E element
CC       enhances the expression in placenta and embryonic kidney.
CC   -!- PTM: Phosphorylated on serine and threonine residues.
CC       {ECO:0000269|PubMed:11806752}.
CC   -!- DISEASE: Opitz GBBB syndrome 1 (GBBB1) [MIM:300000]: A congenital
CC       midline malformation syndrome characterized by hypertelorism,
CC       genital-urinary defects such as hypospadias in males and splayed
CC       labia in females, cleft lip/palate, laryngotracheoesophageal
CC       abnormalities, imperforate anus, developmental delay and
CC       congenital heart defects. {ECO:0000269|PubMed:11030761,
CC       ECO:0000269|PubMed:15558842, ECO:0000269|PubMed:9354791,
CC       ECO:0000269|PubMed:9718340}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. MID1
CC       mutations produce proteins with a decreased affinity for
CC       microtubules.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13667; CAA74018.1; -; mRNA.
DR   EMBL; AF035360; AAB99951.1; -; mRNA.
DR   EMBL; AF041206; AAC32998.1; -; mRNA.
DR   EMBL; AF041207; AAC32999.1; -; mRNA.
DR   EMBL; AF041208; AAC33000.1; -; mRNA.
DR   EMBL; AF041209; AAC33001.1; -; mRNA.
DR   EMBL; AF041210; AAC33002.1; -; mRNA.
DR   EMBL; AF230976; AAG50191.1; -; mRNA.
DR   EMBL; AF230977; AAG50192.1; -; mRNA.
DR   EMBL; AF269101; AAG33130.1; -; mRNA.
DR   EMBL; AK315095; BAG37559.1; -; mRNA.
DR   EMBL; CH471074; EAW98780.1; -; Genomic_DNA.
DR   EMBL; BC053626; AAH53626.1; -; mRNA.
DR   CCDS; CCDS14138.1; -. [O15344-1]
DR   PIR; T09482; T09482.
DR   RefSeq; NP_000372.1; NM_000381.3. [O15344-1]
DR   RefSeq; NP_001092094.1; NM_001098624.2. [O15344-1]
DR   RefSeq; NP_001180206.1; NM_001193277.1. [O15344-1]
DR   RefSeq; NP_001180207.1; NM_001193278.1.
DR   RefSeq; NP_001180208.1; NM_001193279.1.
DR   RefSeq; NP_001180209.1; NM_001193280.1.
DR   RefSeq; NP_001180210.1; NM_001193281.1.
DR   RefSeq; NP_001334662.1; NM_001347733.1. [O15344-1]
DR   RefSeq; NP_150632.1; NM_033290.3. [O15344-1]
DR   RefSeq; XP_016885025.1; XM_017029536.1. [O15344-1]
DR   RefSeq; XP_016885029.1; XM_017029540.1. [O15344-2]
DR   UniGene; Hs.27695; -.
DR   UniGene; Hs.460482; -.
DR   UniGene; Hs.689953; -.
DR   UniGene; Hs.738954; -.
DR   PDB; 2DQ5; NMR; -; A=168-214.
DR   PDB; 2FFW; NMR; -; A=87-164.
DR   PDB; 2JUN; NMR; -; A=114-214.
DR   PDB; 5IM8; NMR; -; A=320-379.
DR   PDBsum; 2DQ5; -.
DR   PDBsum; 2FFW; -.
DR   PDBsum; 2JUN; -.
DR   PDBsum; 5IM8; -.
DR   ProteinModelPortal; O15344; -.
DR   SMR; O15344; -.
DR   BioGrid; 110427; 73.
DR   IntAct; O15344; 39.
DR   STRING; 9606.ENSP00000312678; -.
DR   iPTMnet; O15344; -.
DR   PhosphoSitePlus; O15344; -.
DR   BioMuta; MID1; -.
DR   EPD; O15344; -.
DR   MaxQB; O15344; -.
DR   PaxDb; O15344; -.
DR   PeptideAtlas; O15344; -.
DR   PRIDE; O15344; -.
DR   DNASU; 4281; -.
DR   Ensembl; ENST00000317552; ENSP00000312678; ENSG00000101871. [O15344-1]
DR   Ensembl; ENST00000380779; ENSP00000370156; ENSG00000101871. [O15344-1]
DR   Ensembl; ENST00000380780; ENSP00000370157; ENSG00000101871. [O15344-1]
DR   Ensembl; ENST00000380782; ENSP00000370159; ENSG00000101871. [O15344-2]
DR   Ensembl; ENST00000380785; ENSP00000370162; ENSG00000101871. [O15344-1]
DR   Ensembl; ENST00000380787; ENSP00000370164; ENSG00000101871. [O15344-1]
DR   Ensembl; ENST00000453318; ENSP00000414521; ENSG00000101871. [O15344-1]
DR   GeneID; 4281; -.
DR   KEGG; hsa:4281; -.
DR   UCSC; uc004cte.5; human. [O15344-1]
DR   CTD; 4281; -.
DR   DisGeNET; 4281; -.
DR   GeneCards; MID1; -.
DR   GeneReviews; MID1; -.
DR   HGNC; HGNC:7095; MID1.
DR   HPA; HPA003715; -.
DR   MalaCards; MID1; -.
DR   MIM; 300000; phenotype.
DR   MIM; 300552; gene.
DR   neXtProt; NX_O15344; -.
DR   OpenTargets; ENSG00000101871; -.
DR   Orphanet; 306597; X-linked Opitz G/BBB syndrome.
DR   PharmGKB; PA30816; -.
DR   eggNOG; ENOG410ITFU; Eukaryota.
DR   eggNOG; ENOG410Z43Q; LUCA.
DR   GeneTree; ENSGT00760000118878; -.
DR   HOGENOM; HOG000049193; -.
DR   HOVERGEN; HBG056432; -.
DR   InParanoid; O15344; -.
DR   KO; K08285; -.
DR   OMA; RERAFDS; -.
DR   OrthoDB; EOG091G02K9; -.
DR   PhylomeDB; O15344; -.
DR   TreeFam; TF333654; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   ChiTaRS; MID1; human.
DR   EvolutionaryTrace; O15344; -.
DR   GeneWiki; MID1; -.
DR   GenomeRNAi; 4281; -.
DR   PRO; PR:O15344; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101871; -.
DR   CleanEx; HS_MID1; -.
DR   ExpressionAtlas; O15344; baseline and differential.
DR   Genevisible; O15344; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005875; C:microtubule associated complex; TAS:ProtInc.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008017; F:microtubule binding; IMP:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; TAS:ProtInc.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0035372; P:protein localization to microtubule; IMP:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR003649; Bbox_C.
DR   InterPro; IPR003879; Butyrophylin.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR017903; COS_domain.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR027727; MID1.
DR   InterPro; IPR006574; PRY.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103:SF550; PTHR24103:SF550; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF13765; PRY; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00502; BBC; 1.
DR   SMART; SM00336; BBOX; 2.
DR   SMART; SM00060; FN3; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS51262; COS; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; Metal-binding; Microtubule;
KW   Phosphoprotein; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    667       E3 ubiquitin-protein ligase Midline-1.
FT                                /FTId=PRO_0000056227.
FT   DOMAIN      320    379       COS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00586}.
FT   DOMAIN      381    484       Fibronectin type-III.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      482    659       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   ZN_FING      10     60       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     116    165       B box-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   ZN_FING     172    212       B box-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   COILED      205    264       {ECO:0000255}.
FT   METAL       119    119       Zinc 1.
FT   METAL       122    122       Zinc 1.
FT   METAL       134    134       Zinc 2.
FT   METAL       137    137       Zinc 2.
FT   METAL       142    142       Zinc 1.
FT   METAL       145    145       Zinc 1.
FT   METAL       150    150       Zinc 2.
FT   METAL       159    159       Zinc 2.
FT   MOD_RES      92     92       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     511    511       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     553    667       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_005735.
FT   VARIANT     266    266       C -> R (in GBBB1).
FT                                {ECO:0000269|PubMed:9718340}.
FT                                /FTId=VAR_013758.
FT   VARIANT     295    295       L -> P (in GBBB1; dbSNP:rs104894866).
FT                                {ECO:0000269|PubMed:15558842}.
FT                                /FTId=VAR_025495.
FT   VARIANT     391    392       LC -> R (in GBBB1).
FT                                {ECO:0000269|PubMed:15558842}.
FT                                /FTId=VAR_025496.
FT   VARIANT     438    438       Missing (in GBBB1).
FT                                {ECO:0000269|PubMed:9354791}.
FT                                /FTId=VAR_013759.
FT   VARIANT     534    534       V -> VFIDSGRHL (in GBBB1).
FT                                /FTId=VAR_013760.
FT   VARIANT     536    536       I -> T (in GBBB1).
FT                                {ECO:0000269|PubMed:9718340}.
FT                                /FTId=VAR_013761.
FT   VARIANT     626    626       L -> P (in GBBB1; dbSNP:rs28934611).
FT                                {ECO:0000269|PubMed:11030761}.
FT                                /FTId=VAR_013762.
FT   CONFLICT    228    228       T -> P (in Ref. 3; AAC32999).
FT                                {ECO:0000305}.
FT   CONFLICT    484    484       Q -> P (in Ref. 3; AAC32998).
FT                                {ECO:0000305}.
FT   STRAND      112    114       {ECO:0000244|PDB:2FFW}.
FT   STRAND      124    126       {ECO:0000244|PDB:2FFW}.
FT   STRAND      132    134       {ECO:0000244|PDB:2FFW}.
FT   TURN        135    138       {ECO:0000244|PDB:2FFW}.
FT   STRAND      139    141       {ECO:0000244|PDB:2FFW}.
FT   HELIX       143    149       {ECO:0000244|PDB:2FFW}.
FT   STRAND      154    156       {ECO:0000244|PDB:2FFW}.
FT   STRAND      161    163       {ECO:0000244|PDB:2JUN}.
FT   STRAND      179    181       {ECO:0000244|PDB:2JUN}.
FT   STRAND      185    187       {ECO:0000244|PDB:2DQ5}.
FT   TURN        188    191       {ECO:0000244|PDB:2DQ5}.
FT   STRAND      192    194       {ECO:0000244|PDB:2DQ5}.
FT   HELIX       196    200       {ECO:0000244|PDB:2DQ5}.
FT   STRAND      205    207       {ECO:0000244|PDB:2JUN}.
FT   HELIX       325    346       {ECO:0000244|PDB:5IM8}.
FT   STRAND      352    355       {ECO:0000244|PDB:5IM8}.
FT   HELIX       356    374       {ECO:0000244|PDB:5IM8}.
SQ   SEQUENCE   667 AA;  75251 MW;  673C5120018BA619 CRC64;
     METLESELTC PICLELFEDP LLLPCAHSLC FNCAHRILVS HCATNESVES ITAFQCPTCR
     HVITLSQRGL DGLKRNVTLQ NIIDRFQKAS VSGPNSPSET RRERAFDANT MTSAEKVLCQ
     FCDQDPAQDA VKTCVTCEVS YCDECLKATH PNKKPFTGHR LIEPIPDSHI RGLMCLEHED
     EKVNMYCVTD DQLICALCKL VGRHRDHQVA ALSERYDKLK QNLESNLTNL IKRNTELETL
     LAKLIQTCQH VEVNASRQEA KLTEECDLLI EIIQQRRQII GTKIKEGKVM RLRKLAQQIA
     NCKQCIERSA SLISQAEHSL KENDHARFLQ TAKNITERVS MATASSQVLI PEINLNDTFD
     TFALDFSREK KLLECLDYLT APNPPTIREE LCTASYDTIT VHWTSDDEFS VVSYELQYTI
     FTGQANVVSL CNSADSWMIV PNIKQNHYTV HGLQSGTKYI FMVKAINQAG SRSSEPGKLK
     TNSQPFKLDP KSAHRKLKVS HDNLTVERDE SSSKKSHTPE RFTSQGSYGV AGNVFIDSGR
     HYWEVVISGS TWYAIGLAYK SAPKHEWIGK NSASWALCRC NNNWVVRHNS KEIPIEPAPH
     LRRVGILLDY DNGSIAFYDA LNSIHLYTFD VAFAQPVCPT FTVWNKCLTI ITGLPIPDHL
     DCTEQLP
//
